SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-217024
Filing Date
2020-08-12
Accepted
2020-08-12 07:33:59
Documents
4
Period of Report
2020-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d26762d8k.htm 8-K 16834
2 EX-99.1 d26762dex991.htm EX-99.1 246585
3 GRAPHIC g26762dsp05a.jpg GRAPHIC 7549
4 GRAPHIC g26762dsp05b.jpg GRAPHIC 1709
  Complete submission text file 0001193125-20-217024.txt   277538
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200
Royalty Pharma plc (Filer) CIK: 0001802768 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39329 | Film No.: 201094084
SIC: 2834 Pharmaceutical Preparations